Form 4: XOMA Royalty Corp Chief Investment Officer Increases Stake with Significant Stock Purchase

Bradley Sitko, Chief Investment Officer of XOMA Royalty Corp, has reported an acquisition of 2,000 Depositary Shares, signaling increased insider confidence in the company.

Summary

• Bradley Sitko, Chief Investment Officer of XOMA Royalty Corp, acquired 2,000 Depositary Shares 8.375% Series B Cumulative Stock on June 30, 2025.
• The shares were purchased at a weighted average price of $25.39 per share, with trades ranging from $25.39 to $25.40.
• Following this transaction, Bradley Sitko directly holds 7,045 Depositary Shares 8.375% Series B Cumulative Stock, 13,110 Common Stock, and 313 8.625% Series A Cumulative Perpetual Preferred Stock.
• Indirect holdings include 829 Common Stock via a 401(k) Plan, 1,500 Common Stock and 82 8.625% Series A Cumulative Perpetual Preferred Stock via spouse, and 75 Common Stock each via two children.
• An additional 2,000 Depositary Shares 8.375% Series B Cumulative Stock are held indirectly by spouse.
• The direct common stock holdings include 1,626 shares acquired under the ESPP Plan on May 31, 2025.

Sentiment

Score: 7

Explanation: The sentiment is positive due to the significant insider purchase by a key executive, indicating confidence in the company's valuation and future.

Positives

• The Chief Investment Officer's direct purchase of 2,000 Depositary Shares indicates strong insider confidence in XOMA Royalty Corp's future prospects.
• Insider buying can be a positive signal to the market, suggesting that management believes the stock is undervalued or expects positive developments.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic direction.

Industry Context

Insider purchases, particularly by a Chief Investment Officer, are often interpreted by the market as a sign of management's belief in the company's intrinsic value and future growth potential, potentially signaling a positive outlook within the biotechnology royalty and investment sector.

Comparison to Industry Standards

• Insider buying activity, such as this purchase by XOMA's Chief Investment Officer, is a common signal across industries that management perceives value in their own company's stock.
• While specific comparable companies or projects are not detailed in this Form 4, such transactions are generally viewed favorably, similar to how executives at companies like Royalty Pharma plc or other biotech royalty firms might signal confidence through personal investments.

Related Party Transactions

• The reported transactions involve an insider (Chief Investment Officer Bradley Sitko) acquiring securities of XOMA Royalty Corp, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders may view the Chief Investment Officer's purchase as a positive indicator of the company's prospects, potentially increasing investor confidence.
• The transaction provides transparency to the market regarding insider holdings and their investment decisions.

Key Dates

Recommendation

Keywords

XOMA Royalty Corp, XOMA, insider trading, Form 4, stock ownership, beneficial ownership, Chief Investment Officer, depositary shares, common stock, preferred stock